# Element Solutions Inc: financial statements, quarterly ESI · NYSE · CIK 1590714 · [Materials](/sectors/materials.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/esi.md) · [Financials](/companies/esi/financials.md) · [Filings](/companies/esi/filings.md) · [Insiders](/companies/esi/insiders.md) Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/esi/financials.md?period=annual). ## Income statement | Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [573 d](/filings/0001590714-26-000018.md) | [575](/filings/0001590714-25-000041.md) | [613](/filings/0001590714-25-000077.md) | [645](/filings/0001590714-25-000087.md) | [624 d](/filings/0001590714-26-000018.md) | [594](/filings/0001590714-26-000041.md) | [625](/filings/0001590714-26-000065.md) | [656](/filings/0001590714-26-000073.md) | [676 d](/filings/0001590714-26-000018.md) | [840](/filings/0001590714-26-000041.md) | [978](/filings/0001590714-26-000065.md) | [995](/filings/0001590714-26-000073.md) | | Cost of revenue | $m | [353 d](/filings/0001590714-26-000018.md) | [330](/filings/0001590714-25-000041.md) | [346](/filings/0001590714-25-000077.md) | [378](/filings/0001590714-25-000087.md) | [368 d](/filings/0001590714-26-000018.md) | [343](/filings/0001590714-26-000041.md) | [359](/filings/0001590714-26-000065.md) | [379](/filings/0001590714-26-000073.md) | [400 d](/filings/0001590714-26-000018.md) | [517](/filings/0001590714-26-000041.md) | [644](/filings/0001590714-26-000065.md) | [653](/filings/0001590714-26-000073.md) | | Gross profit | $m | [220 d](/filings/0001590714-26-000018.md) | [245](/filings/0001590714-25-000041.md) | [267](/filings/0001590714-25-000077.md) | [268](/filings/0001590714-25-000087.md) | [256 d](/filings/0001590714-26-000018.md) | [251](/filings/0001590714-26-000041.md) | [266](/filings/0001590714-26-000065.md) | [277](/filings/0001590714-26-000073.md) | [277 d](/filings/0001590714-26-000018.md) | [323](/filings/0001590714-26-000041.md) | [334](/filings/0001590714-26-000065.md) | [342](/filings/0001590714-26-000073.md) | | Research and development | $m | [13.8 d](/filings/0001590714-26-000018.md) | [18.1](/filings/0001590714-25-000041.md) | [15.6](/filings/0001590714-25-000077.md) | [14.9](/filings/0001590714-25-000087.md) | [14.4 d](/filings/0001590714-26-000018.md) | [15.9](/filings/0001590714-26-000041.md) | [16.2](/filings/0001590714-26-000065.md) | [18.1](/filings/0001590714-26-000073.md) | [17.4 d](/filings/0001590714-26-000018.md) | [20.2](/filings/0001590714-26-000041.md) | [19.5](/filings/0001590714-26-000065.md) | [22.9](/filings/0001590714-26-000073.md) | | Selling, general and administrative | $m | [151 d](/filings/0001590714-26-000018.md) | [149](/filings/0001590714-25-000041.md) | [155](/filings/0001590714-25-000077.md) | [158](/filings/0001590714-25-000087.md) | [167 d](/filings/0001590714-26-000018.md) | [157](/filings/0001590714-26-000041.md) | [156](/filings/0001590714-26-000065.md) | [158](/filings/0001590714-26-000073.md) | [190 d](/filings/0001590714-26-000018.md) | [191](/filings/0001590714-26-000041.md) | [201](/filings/0001590714-26-000065.md) | [206](/filings/0001590714-26-000073.md) | | Operating income | $m | [55.5 d](/filings/0001590714-26-000018.md) | [77.8](/filings/0001590714-25-000041.md) | [96.2](/filings/0001590714-25-000077.md) | [95.0](/filings/0001590714-25-000087.md) | [74.9 d](/filings/0001590714-26-000018.md) | [77.4](/filings/0001590714-26-000041.md) | [94.3](/filings/0001590714-26-000065.md) | [101](/filings/0001590714-26-000073.md) | [69.7 d](/filings/0001590714-26-000018.md) | [111](/filings/0001590714-26-000041.md) | [114](/filings/0001590714-26-000065.md) | [114](/filings/0001590714-26-000073.md) | | Interest expense | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Income tax | $m | [(40.4) d](/filings/0001590714-26-000018.md) | [13.5](/filings/0001590714-25-000041.md) | [(17.5)](/filings/0001590714-25-000077.md) | [36.8](/filings/0001590714-25-000087.md) | [12.0 d](/filings/0001590714-26-000018.md) | [17.8](/filings/0001590714-26-000041.md) | [15.8](/filings/0001590714-26-000065.md) | [16.2](/filings/0001590714-26-000073.md) | [24.8 d](/filings/0001590714-26-000018.md) | [26.7](/filings/0001590714-26-000041.md) | [29.8](/filings/0001590714-26-000065.md) | [27.6](/filings/0001590714-26-000073.md) | | Net income | $m | [77.1 d](/filings/0001590714-26-000018.md) | [56.0](/filings/0001590714-24-000089.md) | [93.2](/filings/0001590714-25-000077.md) | [40.3](/filings/0001590714-25-000087.md) | [54.7 d](/filings/0001590714-26-000018.md) | [98.0](/filings/0001590714-26-000041.md) | [47.4](/filings/0001590714-26-000065.md) | [39.3](/filings/0001590714-26-000073.md) | [6.1 d](/filings/0001590714-26-000018.md) | [55.9](/filings/0001590714-26-000041.md) | [77.3](/filings/0001590714-26-000065.md) | [65.7](/filings/0001590714-26-000073.md) | | Diluted EPS | $ per share | not reported | [0.23](/filings/0001590714-25-000041.md) | [0.39](/filings/0001590714-25-000077.md) | [0.17](/filings/0001590714-25-000087.md) | not reported | [0.40](/filings/0001590714-26-000041.md) | [0.20](/filings/0001590714-26-000065.md) | [0.16](/filings/0001590714-26-000073.md) | not reported | [0.23](/filings/0001590714-26-000041.md) | [0.32](/filings/0001590714-26-000065.md) | [0.27](/filings/0001590714-26-000073.md) | | Basic EPS | $ per share | not reported | [0.23](/filings/0001590714-25-000041.md) | [0.39](/filings/0001590714-25-000077.md) | [0.17](/filings/0001590714-25-000087.md) | not reported | [0.40](/filings/0001590714-26-000041.md) | [0.20](/filings/0001590714-26-000065.md) | [0.16](/filings/0001590714-26-000073.md) | not reported | [0.23](/filings/0001590714-26-000041.md) | [0.32](/filings/0001590714-26-000065.md) | [0.27](/filings/0001590714-26-000073.md) | - Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax - Cost of revenue: us-gaap:CostOfGoodsAndServicesSold - Gross profit: us-gaap:GrossProfit - Research and development: us-gaap:ResearchAndDevelopmentExpense - Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense - Operating income: us-gaap:OperatingIncomeLoss - Interest expense: not reported - Income tax: us-gaap:IncomeTaxExpenseBenefit - Net income: us-gaap:NetIncomeLoss - Diluted EPS: us-gaap:EarningsPerShareDiluted - Basic EPS: us-gaap:EarningsPerShareBasic ## Balance sheet | Line item | Unit | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Cash and equivalents | $m | [289](/filings/0001590714-25-000022.md) | [286](/filings/0001590714-24-000089.md) | [309](/filings/0001590714-24-000135.md) | [376](/filings/0001590714-24-000146.md) | [359](/filings/0001590714-26-000018.md) | [499](/filings/0001590714-25-000041.md) | [530](/filings/0001590714-25-000077.md) | [594](/filings/0001590714-25-000087.md) | [627](/filings/0001590714-26-000073.md) | [177](/filings/0001590714-26-000041.md) | [190](/filings/0001590714-26-000065.md) | [225](/filings/0001590714-26-000073.md) | | Current assets | $m | [1,198](/filings/0001590714-25-000022.md) | [1,236](/filings/0001590714-24-000089.md) | [1,302](/filings/0001590714-24-000135.md) | [1,351](/filings/0001590714-24-000146.md) | [1,270](/filings/0001590714-26-000018.md) | [1,361](/filings/0001590714-25-000041.md) | [1,454](/filings/0001590714-25-000077.md) | [1,526](/filings/0001590714-25-000087.md) | [1,583](/filings/0001590714-26-000073.md) | [1,458](/filings/0001590714-26-000041.md) | [1,523](/filings/0001590714-26-000065.md) | [1,577](/filings/0001590714-26-000073.md) | | Total assets | $m | [4,974](/filings/0001590714-25-000022.md) | [4,912](/filings/0001590714-24-000089.md) | [4,982](/filings/0001590714-24-000135.md) | [5,098](/filings/0001590714-24-000146.md) | [4,874](/filings/0001590714-26-000018.md) | [4,795](/filings/0001590714-25-000041.md) | [5,003](/filings/0001590714-25-000077.md) | [5,045](/filings/0001590714-25-000087.md) | [5,101](/filings/0001590714-26-000073.md) | [5,738](/filings/0001590714-26-000041.md) | [5,784](/filings/0001590714-26-000065.md) | [5,861](/filings/0001590714-26-000073.md) | | Current liabilities | $m | [369](/filings/0001590714-25-000022.md) | [341](/filings/0001590714-24-000089.md) | [372](/filings/0001590714-24-000135.md) | [384](/filings/0001590714-24-000146.md) | [380](/filings/0001590714-26-000018.md) | [345](/filings/0001590714-25-000041.md) | [355](/filings/0001590714-25-000077.md) | [377](/filings/0001590714-25-000087.md) | [430](/filings/0001590714-26-000073.md) | [544](/filings/0001590714-26-000041.md) | [524](/filings/0001590714-26-000065.md) | [567](/filings/0001590714-26-000073.md) | | Total liabilities | $m | [2,630](/filings/0001590714-25-000022.md) | [2,573](/filings/0001590714-24-000089.md) | [2,594](/filings/0001590714-24-000135.md) | [2,644](/filings/0001590714-24-000146.md) | [2,476](/filings/0001590714-26-000018.md) | [2,260](/filings/0001590714-25-000041.md) | [2,361](/filings/0001590714-25-000077.md) | [2,376](/filings/0001590714-25-000087.md) | [2,412](/filings/0001590714-26-000073.md) | [2,988](/filings/0001590714-26-000041.md) | [2,957](/filings/0001590714-26-000065.md) | [2,974](/filings/0001590714-26-000073.md) | | Long-term debt | $m | [1,950](/filings/0001590714-24-000054.md) | not reported | not reported | not reported | [1,839](/filings/0001590714-25-000022.md) | not reported | not reported | not reported | [1,636](/filings/0001590714-26-000018.md) | not reported | not reported | not reported | | Current portion of debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Short-term borrowings | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Shareholders' equity | $m | [2,329](/filings/0001590714-25-000022.md) | [2,324](/filings/0001590714-24-000089.md) | [2,373](/filings/0001590714-24-000135.md) | [2,439](/filings/0001590714-24-000146.md) | [2,383](/filings/0001590714-26-000018.md) | [2,520](/filings/0001590714-25-000041.md) | [2,626](/filings/0001590714-25-000077.md) | [2,654](/filings/0001590714-25-000087.md) | [2,675](/filings/0001590714-26-000073.md) | [2,735](/filings/0001590714-26-000041.md) | [2,813](/filings/0001590714-26-000065.md) | [2,873](/filings/0001590714-26-000073.md) | - Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue - Current assets: us-gaap:AssetsCurrent - Total assets: us-gaap:Assets - Current liabilities: us-gaap:LiabilitiesCurrent - Total liabilities: us-gaap:Liabilities - Long-term debt: us-gaap:LongTermDebt - Current portion of debt: not reported - Short-term borrowings: not reported - Shareholders' equity: us-gaap:StockholdersEquity ## Cash flow | Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Operating cash flow | $m | [112 d](/filings/0001590714-26-000018.md) | [58.2](/filings/0001590714-25-000041.md) | [66.6 d](/filings/0001590714-25-000077.md) | [98.5 d](/filings/0001590714-25-000087.md) | [139 d](/filings/0001590714-26-000018.md) | [26.0](/filings/0001590714-26-000041.md) | [72.6 d](/filings/0001590714-26-000065.md) | [100 d](/filings/0001590714-26-000073.md) | [91.1 d](/filings/0001590714-26-000018.md) | [(66.6)](/filings/0001590714-26-000041.md) | [99.6 d](/filings/0001590714-26-000065.md) | [159 d](/filings/0001590714-26-000073.md) | | Capital expenditure | $m | [16.4 d](/filings/0001590714-26-000018.md) | [19.0](/filings/0001590714-25-000041.md) | [14.5 d](/filings/0001590714-25-000077.md) | [12.6 d](/filings/0001590714-25-000087.md) | [22.3 d](/filings/0001590714-26-000018.md) | [11.0](/filings/0001590714-26-000041.md) | [17.7 d](/filings/0001590714-26-000065.md) | [16.5 d](/filings/0001590714-26-000073.md) | [17.0 d](/filings/0001590714-26-000018.md) | [25.1](/filings/0001590714-26-000041.md) | [27.9 d](/filings/0001590714-26-000065.md) | [30.4 d](/filings/0001590714-26-000073.md) | | Dividends paid | $m | [19.3 d](/filings/0001590714-26-000018.md) | [20.0](/filings/0001590714-25-000041.md) | [19.4 d](/filings/0001590714-25-000077.md) | [19.4 d](/filings/0001590714-25-000087.md) | [19.4 d](/filings/0001590714-26-000018.md) | [19.8](/filings/0001590714-26-000041.md) | [19.3 d](/filings/0001590714-26-000065.md) | [19.3 d](/filings/0001590714-26-000073.md) | [19.4 d](/filings/0001590714-26-000018.md) | [20.2](/filings/0001590714-26-000041.md) | [19.6 d](/filings/0001590714-26-000065.md) | [19.5 d](/filings/0001590714-26-000073.md) | | Share repurchases | $m | [0.0 d](/filings/0001590714-26-000018.md) | not reported | not reported | [0.0 d](/filings/0001590714-25-000087.md) | [0.0 d](/filings/0001590714-26-000018.md) | not reported | not reported | [0.0 d](/filings/0001590714-26-000073.md) | [5.6 d](/filings/0001590714-26-000018.md) | not reported | not reported | [37.7 d](/filings/0001590714-26-000073.md) | - Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations, us-gaap:NetCashProvidedByUsedInOperatingActivities - Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment - Dividends paid: us-gaap:PaymentsOfDividends - Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock ## Shares | Line item | Unit | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Diluted shares (weighted) | millions of shares | [242](/filings/0001590714-24-000089.md) | [242](/filings/0001590714-24-000135.md) | [242](/filings/0001590714-24-000146.md) | [243](/filings/0001590714-25-000041.md) | [243](/filings/0001590714-25-000077.md) | [243](/filings/0001590714-25-000087.md) | [243](/filings/0001590714-26-000041.md) | [242](/filings/0001590714-26-000065.md) | [242](/filings/0001590714-26-000073.md) | [244](/filings/0001590714-26-000041.md) | [244](/filings/0001590714-26-000065.md) | [244](/filings/0001590714-26-000073.md) | - Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding Shares outstanding: 242,602,998 at 2026-10-15, from the cover of the [10-Q filed 2026-10-22](/filings/0001590714-26-000073.md) (dei:EntityCommonStockSharesOutstanding). Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:43 ET. No prices; not investment advice.